Clinical Trial Update: Conventional TEVAR Versus FABULOUS RCT [NA]

View source ↗

Summary

Upcoming randomized trial comparing conventional TEVAR to the FABULOUS approach for type B aortic dissection; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Aortic Dissection

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Type B Aortic Dissection | NA | Status: NOT_YET_RECRUITING